Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: Feasibility data

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 3, 2011, Pages 476-482

  Pilie, Patrick G ^a   Ibarra Drendall, Catherine ^a   Troch, Michelle M ^a   Broadwater, Gloria ^a   Barry, William T ^a   Petricoin III, Emanuel F ^b   Wulfkuhle, Julia D ^b   Liotta, Lance A ^b   Lem, Siya ^a   Baker Jr , Joseph C ^a   Stouder, April ^a   Ford, Anne C ^a   Wilke, Lee G ^a   Zalles, Carola M ^c   Mehta, Priya ^a   Williams, Jamila ^a   Shivraj, Melanie ^a   Su, Zuowei ^a   Geradts, Joseph ^a   Yu, Dihua ^d   Seewaldt, Victoria L ^a   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CASPASE 3; CASPASE 7; CHECKPOINT KINASE 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 4G; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PAXILLIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN KINASE P60; STAT3 PROTEIN; UVOMORULIN; VASCULOTROPIN RECEPTOR 2; VIMENTIN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BIOPSY, FINE-NEEDLE; BODY MASS INDEX; BREAST NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, HUMAN; MIDDLE AGED; OBESITY; PILOT PROJECTS; PROTEIN ARRAY ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 79955781655     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0847     Document Type: Article

References (25)

1. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38. (Pubitemid 36459468)
2. Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer 2003;106:96-102. (Pubitemid 36750394)
3. Seewaldt VL, Goldenberg V, Jones LW, Peace C, Broadwater G, Scott V, et al. Overweight and obese perimenopausal and postmenopausal women exhibit increased abnormal mammary epithelial cytology. Cancer Epidemiol Biomarkers Prev 2007;16:613-6. (Pubitemid 46548669)
4. Ewertz M, Jensen MB, Gunnarsdottir KA, Hojris I, Jakobsen EH, Nielsen D, et al. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 2011;29:4-7
5. Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam CM, et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 2004;15:875-84. (Pubitemid 39004342)
6. Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer 2006;13:279-92. (Pubitemid 43886659)
7. Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, et al. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 2003;22:6408-23. (Pubitemid 37281689)
8. Fabian CJ, Kimler BF, Zalles CM, Klemp JR, Kamel S, Zeiger S, et al. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 2000;92:1217-27.
9. Ibarra-Drendall C, Wilke LG, Zalles C, Scott V, Archer LE, Lem S, et al. Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study. Cancer Epidemiol Biomarkers Prev 2009;18:1379-85.
10. Wulfkuhle JD, Aquino JA, Calvert VS, Fishman DA, Coukos G, Liotta LA, et al. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 2003;3:2085-90. (Pubitemid 37414073)
11. Espina V, Mehta AI, Winters ME, Calvert V, Wulfkuhle J, Petricoin EF III, et al. Protein microarrays: molecular profiling technologies for clinical specimens. Proteomics 2003;3:2091-100. (Pubitemid 37414074)
12. Liotta LA, Espina V, Mehta AI, Calvert V, Rosenblatt K, Geho D, et al. Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 2003;3:317-25. (Pubitemid 38340301)
13. NIH.Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 1998;6Suppl 2:51S-209S.
14. Vasilatos SN, Broadwater G, Barry WT, Baker JC Jr, Lem S, Dietze EC, et al. CpG island tumor suppressor promoter methylation in non- BRCA-associated early mammary carcinogenesis. Cancer Epidemiol Biomarkers Prev 2009;18:901-14.
15. Petricoin EF III, Espina V, Araujo RP, Midura B, Yeung C, Wan X, et al. Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res 2007;67:3431-40. (Pubitemid 46724884)
16. Flowers JL, Burton GV, Cox EB, McCarty KS Sr, Dent GA, Geisinger KR, et al. Use of monoclonal antiestrogen receptor antibody to evaluate estrogen receptor content in fine needle aspiration breast biopsies. Ann Surg 1986;203:250-4. (Pubitemid 16011287)
17. Mendez MG, Kojima S, Goldman RD. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J 2010;24:1838-51.
18. Shen WJ, Patel S, Eriksson JE, Kraemer FB. Vimentin is a functional partner of hormone sensitive lipase and facilitates lipolysis. J Proteome Res 2010;9:1786-94.
19. Franke WW, Hergt M, Grund C. Rearrangement of the vimentin cytoskeleton during adipose conversion: formation of an intermediate filament cage around lipid globules. Cell 1987;49:131-41.
20. Lieber JG, Evans RM. Disruption of the vimentin intermediate filament system during adipose conversion of 3T3-L1 cells inhibits lipid droplet accumulation. J Cell Sci 1996;109:3047-58. (Pubitemid 27029274)
21. Martinez-Orozco R, Navarro-Tito N, Soto-Guzman A, Castro-Sanchez L, Perez Salazar E. Arachidonic acid promotes epithelial-to-mesenchymal- like transition in mammary epithelial cells MCF10A. Eur J Cell Biol 2010;89:476-88.
22. Gullicksen PS, Della-Fera MA, Baile CA. Leptin-induced adipose apoptosis: Implicationsforbodyweight regulation.Apoptosis 2003;8:327-35.
23. Dogan S, Hu X, Zhang Y, Maihle NJ, Grande JP, Cleary MP. Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-alpha mice. Breast Cancer Res 2007;9:R91.
24. Accordi B, Espina V, Giordan M, VanMeter A, Milani G, Galla L, et al. Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALL. PLoS One 2010;5:e13552.
25. Rose DP, Haffner SM, Baillargeon J. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 2007;28:763-77. (Pubitemid 350294295)